The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease

  • N. C. Bodick
  • , W. W. Offen
  • , H. E. Shannon
  • , J. Satterwhite
  • , R. Lucas
  • , R. Van Lier
  • , S. M. Paul

Research output: Contribution to journal › Article › peer-review

136   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science